Bryant David Lim - May 14, 2024 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
CLO, Interim CFO, Corp Sec.
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
May 14, 2024
Transactions value $
$0
Form type
4
Date filed
5/16/2024, 04:00 PM
Previous filing
Mar 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (Right to Buy) Award $0 +25K $0.00 25K May 14, 2024 Common Stock 25K $3.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on May 14, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.